Abstract
The external controls discussed in Chap. 10 are derived from normal and/or pathologic archival tissues or more ideally from excess tissues specifically selected and processed for the purpose, with a pre-analytic process matching the test tissues as closely as possible. Reference to Table 9.4 shows that such tissues have limitations, with reference to cost, need for periodic replacement of exhausted blocks and availability (confined to the lab that produces them).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Battifora H. Assessment of antigen damage in immunohistochemistry. The vimentin internal control. Am J Clin Pathol. 1991;96:669–71.
Bogen SA. A root cause analysis into the high error rate in clinical immunohistochemistry. Appl Immunohistochem Mol Morph. 2019;27:329–38.
Bogen SA, Sompuram SR. Recent trends and advances in immunodiagnostics of solid tumors [review]. BioDrugs. 2004;18:387–98.
Capodieci P, Donovan M, Buchinsky H, et al. Gene expression profiling in single cells within tissue. Nat Methods. 2005;2:663–5.
Cheung CC, D’Arrigo C, Dietel M, et al. Evolution of quality assurance for clinical immunohistochemistry in the era of precision medicine—part 4: tissue tools for quality assurance in immunohistochemistry. From the international society for immunohistochemistry and molecular morphology (ISIMM) and international quality network for pathology (IQN path). Appl Immunohistochem Mol Morph. 2017;25:227–30.
Conan Doyle A. The adventures of Sherlock Holmes. Adventure XI. The adventure of the Beryl coronet. Strand Mag. 1892;3:511–25.
De Bono E. Lateral thinking. London: Pelican Books; 1970.
Fulton R. Getting a grip on Ki67. Appl Immunohistochem Mol Morph. 2021;29:83–5.
Gu J, Taylor CR. Practicing pathology in the era of big data and personalized medicine. Appl Immunohistochem Mol Morph. 2014;22:1–9.
Ingram M, Tachy GB, Ward BR, et al. Tissue engineered tumor models. Biotech Histochem. 2010;85:213–9.
Jasani B, Thomas ND, Navabi H, Millar DM, Newman GR, Gee J, Williams ED. Dinitrophenyl (DNP) hapten sandwich staining (DHSS) procedure: a 10-year review of its principal reagents and applications. J Immunol Methods. 1992;150(1–2):193–8.
Jensen K, Krusenstjerna-Hafstrøm R, Lohse J, Petersen KP, Derand H. A novel quantitative immunohistochemistry method for precise protein measurements directly in formalin-fixed, paraffin-embedded specimens: analytical performance measuring HER2. Mod Pathol. 2017;30:180–93. https://doi.org/10.1038/modpathol.2016.176.
Kaur P, Ward B, Saha B, Young L, Groshen S, Techy G, Lu Y, Atkinson R, Taylor CR, Ingram M, Imam A. Human breast cancer histioid: an in vitro 3D co-culture model that mimics breast tumor tissue. J Histochem Cytochem. 2011;59:1087–100.
Koppel C, Schwellenbach H, Zielinski D, Eckstein S, Martin-Ortega M, D’Arrigo C, Schildhaus H-U, Ruschoff J, Jasani B. Optimization and validation of PD-L1 immunohistochemistry staining protocols using the antibody clone 28-8 on different staining platforms. Mod Pathol. 2018;31:1630–44.
Maund S, Nolley R, Peehl D. Optimization and comprehensive characterization of a faithful tissue culture model of the benign and malignant human prostate. Lab Investig. 2014;94:208–21. https://doi.org/10.1038/labinvest.2013.141.
Millar DA, Williams ED. A step-wedge standard for the quantification of immunoperoxidase techniques. Histochem J. 1982;14:609–20. https://doi.org/10.1007/BF01011893.
Mire-Sluis A, Ritter N, Cherney B, Schmalzing D, Blumel M. Reference standards for therapeutic proteins: current regulatory and scientific best practices and remaining needs. Part 1. BioProcess Int. 2014a;12(3):26–36. https://bioprocessintl.com/upstream-processing/assays/reference-standards-for-therapeutic-proteins-350518/
Mire-Sluis A, Ritter N, Cherney B, Schmalzing D, Blumel M. Reference standards for therapeutic proteins: current regulatory and scientific best practices and remaining needs. Part 2. BioProcess Int. 2014b;12(5):12–38. https://bioprocessintl.com/2014/reference-standards-for-therapeutic-proteins-351584/
Neumeister VM, Parisi F, England AM, et al. Models and techniques. A tissue quality index; an intrinsic control for measurement of effects of pre-analytic variables on FFPE tissue. Lab Investig. 2014;94:467–74.
Pagliarulo V, George B, Beil SJ, Groshen S, Laird PW, Cai J, Willey J, Cote RC, Datar RH. Sensitivity and reproducibility of standardized competitive RT-PCR for transcript quantification and its comparison with real time RT-PCR. Mol Cancer. 2004;3:5. https://doi.org/10.1186/1476-4598-3-5.
Parry S, Dowsett M, Dodson A. UKNEQAS ICC & ISH Ki67 data reveals differences in performance of primary antibody clones. Appl Immunohistochem Mol Morph. 2021;29:86–94.
Phillips T, Simmons P, Inzunza HD, Cogswell J, Novotny J, Taylor CR, Zhang X. Development of an automated PD-L1 immunohistochemistry (IHC) assay for non small cell lung cancer. Appl Immunohistochem Mol Morph. 2015;23:541–9. https://doi.org/10.1097/PAI.0000000000000256.
Riera J, Simpson JF, Tamayo R, Battifora H. Use of cultured cells as a control for quantitative immunocytochemical analysis of estrogen receptor in breast cancer. The Quicgel method. Am J Clin Pathol. 1999;111:329–35.
Roge R, Nielsen S, Riber-Hanssen R, Vyberg M. Image analysis assessed cell lines as potential performance controls of Ki67 immunostained slides. Appl Immunohistochem Mol Morph. 2021a;29:95–8.
Roge R, Nielsen S, Riber-Hanssen R, Vyberg M. Ki67 proliferation index in breast cancer as a function of assessment method: a NordiQC experience. Appl Immunohistochem Mol Morph. 2021b;29:99–104.
Shi S-R, Liu C, Balgley BM, Lee C, Taylor CR. Protein extraction from formalin-fixed, paraffin embedded tissue sections: quality evaluation by mass spectrometry. J Histochem Cytochem. 2006;54:739–43.
Sompuram SR, Vani K, Hafer LJ, Bogen SA. Antibodies immunoreactive with formalin-fixed tissue antigens recognize linear protein epitopes. Am J Clin Pathol. 2006;125:82–90.
Taylor CR. Quantifiable internal reference standards for immunohistochemistry: the measurement of quantity by weight. Appl Immunohistochem Mol Morph. 2006;14:253–9.
Taylor CR, Cote RJ, editors. Immunomicroscopy: a diagnostic tool for the surgical pathologist. 3rd ed. Philadelphia: Elsevier Saunders; 2005. (1st edition, Taylor was 1986; 2nd edition, Taylor and Cote was 1994).
Taylor CR. Predictive biomarkers and companion diagnostics. The future of immunohistochemistry—‘in situ proteomics’, or just a ‘stain’? Appl Immunohistochem Mol Morph. 2014;22:555–61.
Taylor CR. Quantitative in situ proteomics; a proposed pathway for quantification of immunohistochemistry at the light-microscopic level. Cell Tissue Res. 2015;360:109–20.
Taylor CR. Introduction to predictive biomarkers: definitions and characteristics. In: Badve S, Kumar G, editors. Predictive biomarkers in oncology: applications in precision medicine. Berlin: Springer Sciences; 2019.
Taylor CR, Becker KF. Liquid morphology: immunochemical analysis of proteins extracted from formalin fixed paraffin embedded tissues: combining proteomics with immunohistochemistry. Appl Immunohistochem Mol Morph. 2011;19:1–9.
Taylor CR, Burns J. The demonstration of plasma cells and other immunoglobulin- containing cells in formalin-fixed, paraffin-embedded tissues using peroxidase-labelled antibody. J Clin Pathol. 1974;27:14–20.
Taylor CR, Levenson RM. Quantification of immunohistochemistry—issues concerning methods, utility and semiquantitative assessment. Histopathology. 2006;49:411–24.
Van den Berg EJ, Duarte R, Dickens C, et al. Ki67 immunohistochemistry quantification i breast carcinoma: a comparison of visual estimation, counting and immunoratio. Appl Immunohistochem Mol Morph. 2021;29:105–11.
Van der Ploeg M, Duijndam WAL. Matrix models: essential tools for microscopic cytochemical research. Histochemistry. 1986;84:283–300.
Vani K, Sompuram SR, Fitzgibbons P, Bogen SA. National HER2 proficiency test results using standardized quantitative controls: characterization of laboratory failures. Arch Pathol Lab Med. 2008;132:211–6.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Jasani, B., Huss, R., Taylor, C.R. (2021). Analytical Phase: Alternative and New Control Systems. In: Precision Cancer Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-84087-7_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-84087-7_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-84086-0
Online ISBN: 978-3-030-84087-7
eBook Packages: MedicineMedicine (R0)